O'Brien Stephanie Monaghan (CIK 1720907) reported 9 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-14). Recent activity: Sell APLS (25,666 shares), Sell APLS (5,750 shares), Sell APLS (3,062 shares), Sell APLS (5,744 shares), Sell APLS (7,961 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 25,666 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 5,750 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 3,062 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 5,744 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 7,961 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 3,877 | $0 |
| 2026-05-14 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Sell | 3,544 | $0 |
| 2026-04-08 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Buy | 5,750 | $0 |
| 2026-01-05 | Apellis Pharmaceuticals, Inc. (APLS) | Director | Buy | 7,961 | $0 |
Source: SEC Form 4 filings · as of 2026-05-14